SAPs and Africa

About This Presentation
Title:

SAPs and Africa

Description:

A recent review of available studies on structural adjustment and health for a ... UK prime minister Tony Blair's Commission for Africa notes: ... – PowerPoint PPT presentation

Number of Views:41
Avg rating:3.0/5.0
Slides: 30
Provided by: sarp4
Learn more at: https://sarpn.org

less

Transcript and Presenter's Notes

Title: SAPs and Africa


1
SAPs and Africa
  • In Africa, SAPs have resulted in significant
    macro-economic policy changes and public sector
    restructuring and reduced social provisioning,
    with negative effects on education, health and
    social services for the poor. A recent review of
    available studies on structural adjustment and
    health for a WHO commission states 'The majority
    of studies in Africa, whether theoretical or
    empirical, are negative towards structural
    adjustment and its effects on health outcomes
  • Sanders, D. in Globalisation, health and health
    services in
  • Sub-Saharan Africa available from
    http//www.choike.org/

2
SAPs and Health
the median per capita health budget for
sub-Saharan Africa is US6 and that the mean for
the lowest income African countries is US3.
According to the WHO, US60 is required per
person per annum to deliver a basic level of
health care. (Bond and Dor 2003)
3
What are the values?
  • The UDHR (Universal Declaration of Human Rights)
    (Article 25) cites the right to " a standard of
    living adequate for the health and wellbeing of
    himself and of his family, including food,
    clothing, housing and medical care and necessary
    social services" and the International
    Covenant on Economic, Social and Cultural Rights
    (ICESCR) (UNICESCR, 1966) in Article 12 the
    right of everyone to the enjoyment of the highest
    attainable standard of physical and mental
    health. (London 2004)

4
The challenges
  • the challenges posed by neoliberal
    globalisation to our values of equity and social
    justice, to government ability and flexibility to
    implement the public policies that we choose and
    to the public sector health and essential
    services and that are critical for our health
    (EQUINET 2004)

5
Health and the WTO
  • WTO agreements limit sovereignty of state
  • WB/IM F conditionalities also limit sovereign
    rights of state
  • NEED EXPLICIT RECOGNITION THAT INTERNATIONAL
    AGREEMENTS SHALL NOT LIMIT RIGHTS OF STATES TO
    PROMOTE AND PROTECT HEALTH

6
International Trade Justice?
  • For discussion
  • If a country wins at the DSB, it can retaliate
    by imposing sanctions on the offending country.
  • If a big or developed country imposes sanctions
    on a small or developing country, this would have
    significant impact if their trade constituted a
    substantial share of total trade of that country.
  • Scenario One
  • What would happen if a small or developing
    country won and imposed sanctions on a large or
    developed country?
  • Could it hurt the big country?
  • Scenario Two
  • What would happen if there was a dispute between
    two large or developed countries?

7
Nutrition
  • Nutrition is the key determinant of health status
  • Up to two-thirds of all Africans in this region
    live in rural areas, trying to make a living from
    often marginal land with little opportunity to
    earn wages. Three-quarters of those living in
    rural areas also live below the poverty line.
    Agriculture contributes 35 to the southern
    African regional GDP and 13 of total export
    earnings (SADC, 2004). In addition, about 70 of
    the population of the region depends on
    agriculture for food, income and employment. The
    impact of immediate factors such as drought,
    flooding and unseasonal weather have combined
    with underlying factors such as continual
    poverty, effects of structural adjustment
    programmes and HIV and AIDS to undermine food
    security and the states capacity to respond to
    household food insecurity. In 2003 this resulted
    in more than 16 million people in southern Africa
    suffering from food shortages. More than half the
    Zimbabwean population, over a third of the
    populations of Malawi and Lesotho, a quarter of
    all Zambians and one in 20 Mozambicans needed
    emergency assistance up until the harvests in
    2003. (Chopra)

8
Nutrition and Trade
  • UK prime minister Tony Blairs Commission for
    Africa notes
  • We live in a world where rich nations spend as
    much as the entire income of all the people in
    Africa subsidising the unnecessary production of
    unwanted food to the tune of almost US1
    billion a day, while in Africa hunger is a key
    factor in more deaths than all the continents
    infectious diseases put together. We live in a
    world where every cow in Europe has received
    almost US2 a day in subsidies double,
    grotesquely, the average income in Africa.

9
Trade Related Intellectual Property
Rights(TRIPs)Riaz Tayob obo Rangarirai
MachemedzeSEATINI ZimbabweEJN Conference29
November 2005South Africa
10
Key Messages TRIPs
  • Intellectual Property Rights protection has
    become a more recently a compulsory policy
    through WTO.
  • Protection of Intellectual Property Rights is
    argued to enhance investment in innovation. It
    can however create scarcity of technologies,
  • TRIPS is an agreement now under the WTO and
    provides for a 20 year intellectual property
    protection on patents
  • TRIPs provides flexibilities that countries can
    use to reverse the scarcity of technology rich
    goods like patented pharmaceutical drugs.

11
IPRs
  • What is an intellectual property right?
  • An intellectual property is a creation of the
    mind
  • inventions that are
  • New
  • Involve an inventive step that is non obvious
  • are capable of industrial application - useful
  • TRIPs agreement has minimum standards of
    protection
  • 20 years exclusivity on production, sale and
    offer for sale

12
What is excluded?
  • States may also exclude the following from being
    patented
  • diagnostic, therapeutic and surgical methods for
    the treatment of humans or animals
  • plants and animals and essentially biological
    processes for the production of plants and
    animals

13
TRIPs
  • What purpose does it serve?
  • protection through exclusive rights, in order to
    give adequate returns to the innovators
  • exchange disclosure for exclusivity
  • monopoly right
  • Argument against IPR protection
  • innovation will occur whether there is protection
    or not that
  • innovation depends largely on a body of publicly
    funded knowledge
  • RD spend is lower than marketing spend

14
Discussion point
  • Is a discovery an invention
  • Is the discovery or rediscovery of a plant
  • used by indigenous people capable of being
  • patented?
  • Is it new or is it novel?
  • Who owns this knowledge?
  • Can a community own a patent?

15
Dicoveries vs. Inventions
  • Can be protected by independent system
  • Called sui generis system
  • OAU has model law
  • TRIPs rights are individualistic
  • Indigenous rights are communal
  • Need to pass laws to
  • prevent biopiracy
  • promote informed consent
  • Benefit sharing

16
Impact of TRIPs
  • Scarcity of Drugs access issue
  • Higher prices
  • Production of new medicines limited to patent
    holder
  • Commodification of drugs

17
Nasty Figures
  • Need to dispel some myths in the Pharmaceutical
    industry
  • Disease burden 18 Malaria, TB Pneumonia yet
    0.2 RD
  • RD prefers Sexual Impotence, Balding Obesity
  • More spent on MARKETTING than RD

18
Price Differentiation
19
More Anomalies
  • 2001 saw 79 drop in the price of certain ARVs
    in Brazil once generic equivalents produced
  • Inter company prices between subsidiaries have
    mark ups of sometimes 3000 to 7000
  • The Pharmaceutical business is big business

20
Discussion Point
  • Developed countries did not universally protect
    patents on chemicals and pharmaceutical drugs.
  • Many only adopted these protections late in the
    20th century.
  • Spain did in 1992
  • Switzerland in 1978.
  • Used it as a developmental policy aimed at
  • providing access to drugs, and
  • development of a domestic pharmaceutical sector.
    (Chang 2001)
  • What positive and negative consequences do
    patents imply for access to anteretrovirals and
    new drugs for TB and Malaria in east and southern
    Africa?
  • Do countries in ESA patent their own traditional
    medicines? Why?

21
Flexibilities under TRIPs
  • Flexibilities to exclusive monopoly rights exist
    in TRIPs agreement
  • Compulsory Licensing
  • Government Use
  • Practically
  • Importation (buying from another country)
  • Local production (manufacturing the product
    locally)
  • Export (a country with production capacity can
    export it to those who need it).

22
Protecting Policy Flexibilities
  • Policy Flexibilities under attack _at_
  • WTO
  • Regional Agreements
  • Bilaterally
  • Attack seeks to
  • Increase patent protection
  • Remove flexibilities

23
Government Use
  • If a product is for government use then there is
    no need to respect patent laws.
  • Condition public non-commercial use.

24
Compulsory License
  • A compulsory license is a non-voluntary license -
    given without the consent of the patent holder
  • Is given by an official authority for the use of
    a patented invention
  • The reasons include
  • national emergencies
  • anticompetitive practices by the patent holder
  • public health reasons
  • to protect national security interests
  • local production or
  • parallel importation.

25
Parallel Importation
  • Countries import a patented product from foreign
    market because it is cheaper
  • May be patented or a generic drug still under
    patent (CL)
  • Article 31(f) states that production under
    compulsory license will be primarily for domestic
    consumption
  • States have flexibility for exhaustion of
    rights

26
Additional Flexibility
  • Article 30 of TRIPS provides that
  • Exceptions to Rights Conferred
  • Members may provide limited exceptions to the
    exclusive rights conferred by a patent, provided
    that such exceptions do not unreasonably conflict
    with a normal exploitation of the patent and do
    not unreasonably prejudice the legitimate
    interests of the patent owner, taking account of
    the legitimate interests of third parties

27
What to do?
  • Implement laws to
  • Fully use TRIPs flexibilities
  • Protect indigenous knowledge
  • Resist WTO creep in Bilateral or Regional
    Agreements
  • Monitor prices of drugs

28
AU Ministerial Extraordinary Session
  • Africa Group Proposal
  • Address countries with limited or no local
    production capacity
  • Remove asterisk footnote on Chairman's text
  • Remove impediments to access
  • Workable agreement
  • AU meeting
  • First'reach expeditious' agreement before Hong
    Kong
  • Then 'reach appropriate/workable agreement'
  • In terms of para 11 of Doha
  • Changed in terms of General Council Decision 31
    Aug

29
Role of big countries
  • Wanted a workable solution not only expeditious
  • Members added in
  • SA/Kenya change to conform to para 11
  • Then remove appropriate because duplication
  • Then change to General Council Decision
  • Implicit retraction of progressive position Not
    explicit
Write a Comment
User Comments (0)